-
Fundraiser to benefit local woman recently diagnosed with breast cancer
21 Jan 2026 01:53 GMT
… with invasive ductal carcinoma (breast cancer) along with metastatic carcinoma of the lymph …
-
<![CDATA[FDA Grants Priority Review to Gedatolisib for Advanced Breast Cancer]]>
21 Jan 2026 01:40 GMT
… wild-type, locally advanced or metastatic breast cancer. This indication applies to patients … in HR+/HER2- metastatic breast cancer and provides corporate update. News … patients with advanced or metastatic HR+/HER2- breast cancer (VIKTORIA-1) ( …
-
<![CDATA[FDA Accepts NDA for Gedatolisib in HR+/HER2–, PIK3CA Wild-Type Breast Cancer]]>
20 Jan 2026 22:44 GMT
… with HR+/HER2- advanced breast cancer,” Brian Sullivan, chief executive … or cytologically confirmed metastatic or locally advanced breast cancer. Eligible patients had … /PIK3CA wild-type advanced breast cancer. News release. Celcuity. January …
-
Glycyrrhizin Boosts PTEN, Inhibits Breast Cancer Growth
20 Jan 2026 21:24 GMT
… affecting women worldwide.
Breast cancer pathogenesis is notoriously … tumor growth and metastasis. These mechanistic insights … models bearing human breast cancer tumors. Consistent with … 03268-9
Tags: breast cancer cellular proliferationbreast cancer …
-
Psychosocial Adaptation in Breast Cancer Patients: A Mixed-Methods sequential Explanatory Study
20 Jan 2026 19:25 GMT
… potential for recurrence and metastasis. These patients are … for breast cancer, and 93.1% of breast cancer survivors … on breast cancer outcome: a systematic review. Breast Cancer Res. … and breast cancer mortality in the after breast cancer pooling project …
-
Anyone Can Develop Breast Cancer, Man or Woman
20 Jan 2026 18:36 GMT
… Riverside-based charity that supports breast cancer patients.
Never miss a BVN … range of essential services to breast cancer survivors, including:
Financial support
To … , whose mother, Carmen, died of metastatic breast cancer at age 30.
One of …
-
Enhertu wins Korean approval for HER2-low and HER2-ultra-low metastatic breast cancer
20 Jan 2026 08:41 GMT
… HER2-ultra-low metastatic breast cancer.
The newly … -positive (HR+) metastatic breast cancer. Chemotherapy follows if … -ultra-low expression metastatic breast cancer. Furthermore, Enhertu … breast cancer, accounting for about 70 percent of all breast cancers …
-
Celcuity Announces FDA Acceptance of New Drug Application for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer
20 Jan 2026 12:30 GMT
… and wild-type breast tumor cells in nonclinical … darolutamide in patients with metastatic castration resistant prostate cancer … ;mTOR inhibitors in breast cancer models. NPJ Breast Cancer, 2024;10(1 … , HER2-negative advanced breast cancer: results from the …
-
<![CDATA[EMA Validates T-DXd for First-Line HER2+ Metastatic Breast Cancer]]>
19 Jan 2026 23:33 GMT
… patients with HER2 positive metastatic breast cancer. News release. Daiichi Sankyo … pertuzumab in HER2-positive metastatic breast cancer (DESTINY-Breast09). ClinicalTrials.gov … with HER2+ advanced/metastatic breast cancer: additional analyses of DESTINY …
-
Four New Markers Improve Detection of Aggressive Breast Cancer
20 Jan 2026 11:19 GMT
… the types of breast cancer, triple negative breast cancer (TNBC) is … powerful indicator of cancer metastasis, has been challenging … biopsy technology for aggressive breast cancers. Being able to … cells in metastatic triple-negative breast cancer. Cancer Res …